A Periaortitis Patient Who Succumbed to COVID-19 While Undergoing Systemic Steroid Therapy: A Case Report and Literature Review
- 20 August 2021
- journal article
- review article
- Published by International Scientific Information, Inc. in The American Journal of Case Reports
- Vol. 22, e932733
- https://doi.org/10.12659/AJCR.932733
Abstract
Objective: Unusual clinical course Background: Periaortitis is an inflammatory condition that typically involves the infrarenal portion of the abdominal aorta. It is a rare disease usually occurring in middle-aged men. Coronavirus disease-2019 (COVID-19) is caused by the SARS-CoV-2 virus. The published literature on the management of steroid therapy in patients with periaortitis and infected with SARS-CoV-2 is lacking. The balance between the indispensable anti-inflammatory properties of steroids and their adverse immunosuppressive characteristics remains unclear in the current COVID-19 scenario, and most of the current practices in managing potentially autoimmune aortic conditions are extrapolated from patients with rheumatological disorders contracting COVID19 while undergoing maintenance steroid therapy. Case Report: This report describes the case of a 62-year-old man who presented with nonspecific lower abdominal pain, unremarkable clinical exam, significantly elevated CRP level, and positive antinuclear antibody test. A CT scan showed mild aortic aneurysmal dilatation with periaortic soft tissue thickening, and a PET scan confirmed the finding, showing active abdominal periaortitis. Accordingly, he was diagnosed with autoimmune periaortitis and was maintained on a high dose of systemic corticosteroids (35 mg prednisolone/d). Eight weeks later, he was readmitted to the intensive care unit with worsening respiratory symptoms due to SARS-CoV-2 infection confirmed by PCR test, and unfortunately died 44 days later due to COVID-19-induced respiratory failure and sepsis. Conclusions: The lack of an international consensus on the management of SARS-CoV-2-positive, steroid-dependent patients with serious inflammatory aortic conditions mandates further investigations and thoughtful review of the guidelines for the management of steroid-dependent patients contracting SARS-CoV-2 infection. Additionally, a comprehensive analysis of the outcomes of these patients is essential.This publication has 19 references indexed in Scilit:
- AGA Clinical Practice Update on Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: Expert CommentaryGastroenterology, 2020
- COVID-19 and immunomodulation in IBDGut, 2020
- Aortitis and periaortitis: The puzzling spectrum of inflammatory aortic diseasesLa Presse Médicale, 2020
- Antiviral treatment of COVID-19TURKISH JOURNAL OF MEDICAL SCIENCES, 2020
- Retroperitoneal fibrosis; a single-centre case experience with literature reviewRheumatology Advances in Practice, 2018
- Role of C-Reactive Protein at Sites of Inflammation and InfectionFrontiers in Immunology, 2018
- [ 18 F]-Fluorodeoxyglucose Positron Emission Tomography and Response to Therapy in Idiopathic Retroperitoneal FibrosisEuropean Urology, 2018
- Retroperitoneal fibrosis – the state-of-the-artRheumatology, 2016
- Retroperitoneal fibrosis with periaortitis: A case report of an unusual form of presentation of granulomatosis with polyangiitisRespiratory Medicine Case Reports, 2016
- Chronic periaortitisRheumatology, 2004